Artivion, Inc.

Kennesaw, Georgia-based Artivion, which reported third-quarter revenues of $95.8 million, is a leading cardiac and vascular surgery company focused on aortic disease. Artivion’s four major groups of products include: Aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide.